Teon Therapeutics
Redwood City
About Teon Therapeutics
Teon Therapeutics is a clinical-stage biopharmaceutical company dedicated to improving the lives of cancer patients by developing a focused portfolio of small molecules that inhibit the immunosuppressive and cancer-promoting signaling pathways in the tumor microenvironment. Teon's lead program is an A2BR-specific antagonist that will enter Phase1b trials in 2021.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $37.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Feb 2021)
- Website: teontherapeutics.com
- Phone: +1 650 486 1902
Industries & Categories
Biopharma, Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/teon-therapeutics-36081 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.